Zaremba Rabourn Amy 4
4 · Opus Genetics, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Transactions
- Award
Common Stock
2025-03-13+39,500→ 113,968 total - Award
Employee Stock Option (right to buy)
2025-03-13+39,500→ 39,500 totalExercise: $0.93Exp: 2035-03-12→ Common Stock (39,500 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.
- [F2]The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.